About HERV-H LTR-associating protein 2
HERV-H LTR-associating protein 2 (HHLA2) is a protein
from Homo sapiens identified by UniProt accession
Q9UM44, 414 residues long.
MolForge cross-references it against 0 known binders and
134 disease associations.
Target properties
| Protein name | HERV-H LTR-associating protein 2 |
| UniProt accession | Q9UM44 |
| Gene | HHLA2 |
| Organism | Homo sapiens |
| Length | 414 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (134)
Diseases linked to this target (Open Targets).
- mathematical ability · score 0.45
- body mass index · score 0.42
- cognitive function measurement · score 0.39
- self reported educational attainment · score 0.39
- age at first sexual intercourse measurement · score 0.39
- body weight · score 0.38
- smoking status measurement · score 0.34
- antisocial behaviour measurement · score 0.32
- attention deficit hyperactivity disorder · score 0.32
- substance abuse · score 0.32
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9UM44-F1 | alphafold | PREDICTED | 80.94 | — |
Amino-acid sequence (414 residues)
MKAQTALSFF LILITSLSGS QGIFPLAFFI YVPMNEQIVI GRLDEDIILP SSFERGSEVV IHWKYQDSYK VHSYYKGSDH LESQDPRYAN RTSLFYNEIQ NGNASLFFRR VSLLDEGIYT CYVGTAIQVI TNKVVLKVGV FLTPVMKYEK RNTNSFLICS VLSVYPRPII TWKMDNTPIS ENNMEETGSL DSFSINSPLN ITGSNSSYEC TIENSLLKQT WTGRWTMKDG LHKMQSEHVS LSCQPVNDYF SPNQDFKVTW SRMKSGTFSV LAYYLSSSQN TIINESRFSW NKELINQSDF SMNLMDLNLS DSGEYLCNIS SDEYTLLTIH TVHVEPSQET ASHNKGLWIL VPSAILAAFL LIWSVKCCRA QLEARRSRHP ADGAQQERCC VPPGERCPSA PDNGEENVPL SGKV
Explore HERV-H LTR-associating protein 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets